For example, CXCR4 inhibition with AMD3100 treatment led to increased T cell-mediated antitumor activity with concomitant reduction of Tregs, which resulted in improved survival in ovarian cancer and melanoma immunocompetent mouse models (74). Here, CXCR4 is linked to ovarian carcinoma.